查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1552958

胜肽治療合約 API 製造市場（使用的合成方法類型和營運規模）-2024-2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Peptide Therapeutics Contract API Manufacturing Market (Type of Synthesis Method Used and Scale of Operation ) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 126 Pages | 商品交期: 2-10個工作天內

價格

胜肽治療合約 API 製造市場 - 報告範圍

TMR 關於全球胜肽治療合約 API 製造市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。期間治療藥物合約API 製造市場，考慮2024 年為基準年，2034 年為預測年。該報告也提供了2024年至2034年全球胜肽治療合約API製造市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解胜肽療法合約 API 製造市場。

市場概況
2023年市場價值 25億美元
2034 年市場價值 52 億美元
複合年成長率 6.8%

該報告深入研究了全球肽治療合約 API 製造市場的競爭格局。全球胜肽治療藥物合約 API 製造市場的主要參與者已經確定，並且每個參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球胜肽治療合約 API 製造市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依經營規模

  • 簡介與定義
  • 主要發現/進展
  • 市值預測：2020-2034年依經營規模
    • 臨床前/臨床
    • 商業的
  • 市場吸引力分析：按經營規模

第 7 章：全球市場分析與預測：按所用合成方法類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按所用合成方法類型，2020-2034年
    • 非化學合成法
    • 化學合成法
  • 市場吸引力分析：按所用合成方法類型

第 8 章：全球市場分析與預測：依企業類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依企業類型，2020-2034年
    • 大型企業
    • 中小企業
  • 市場吸引力分析：依企業類型

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2023）
  • 公司簡介
    • Ambiopharm Inc
    • Auspep
    • Bachem Holding AG
    • BCN Peptides
    • Chinese Peptide Company
    • CordenPharma
    • CPC Scientific
    • Creative Peptides
    • CSBio
    • Hybio Pharmaceutical
    • Peptide Institute, Inc.
    • PolyPeptide Group
    • ScinoPharm
    • Senn Chemicals AG
Product Code: TMRGL86348

Peptide Therapeutics Contract API Manufacturing Market - Scope of Report

TMR's report on the global peptide therapeutics contract API manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global peptide therapeutics contract API manufacturing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide therapeutics contract API manufacturing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peptide therapeutics contract API manufacturing market.

Market Snapshot
Market Value in 2023US$ 2.5 Bn
Market Value in 2034US$ 5.2 Bn
CAGR6.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide therapeutics contract API manufacturing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peptide therapeutics contract API manufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide therapeutics contract API manufacturing market.

The report delves into the competitive landscape of the global peptide therapeutics contract API manufacturing market. Key players operating in the global peptide therapeutics contract API manufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peptide therapeutics contract API manufacturing market profiled in this report.

Key Questions Answered in Global peptide therapeutics contract API manufacturing Market Report:

  • What is the sales/revenue generated by peptide therapeutics contract API manufacturing across all regions during the forecast period?
  • What are the opportunities in the global peptide therapeutics contract API manufacturing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Peptide Therapeutics Contract API Manufacturing Market - Research Objectives and Research Approach

The comprehensive report on the global peptide therapeutics contract API manufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peptide therapeutics contract API manufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peptide therapeutics contract API manufacturing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Peptide Therapeutics Contract API Manufacturing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Scale of Operation

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 6.3.1. Preclinical/Clinical
    • 6.3.2. Commercial
  • 6.4. Market Attractiveness Analysis, by Scale of Operation

7. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Type of Synthesis Method Used

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 7.3.1. Non-chemical Synthesis Method
    • 7.3.2. Chemical Synthesis Method
  • 7.4. Market Attractiveness Analysis, by Type of Synthesis Method Used

8. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Enterprise Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Enterprise Type, 2020-2034
    • 8.3.1. Large Enterprise
    • 8.3.2. Small and Medium Enterprise
  • 8.4. Market Attractiveness Analysis, by Enterprise Type

9. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 10.3.1. Preclinical/Clinical
    • 10.3.2. Commercial
  • 10.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 10.4.1. Non-chemical Synthesis Method
    • 10.4.2. Chemical Synthesis Method
  • 10.5. Market Value Forecast, by Enterprise Type, 2020-2034
    • 10.5.1. Large Enterprise
    • 10.5.2. Small and Medium Enterprise
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Scale of Operation
    • 10.7.2. By Type of Synthesis Method Used
    • 10.7.3. By Enterprise Type
    • 10.7.4. By Country

11. Europe Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 11.3.1. Preclinical/Clinical
    • 11.3.2. Commercial
  • 11.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 11.4.1. Non-chemical Synthesis Method
    • 11.4.2. Chemical Synthesis Method
  • 11.5. Market Value Forecast, by Enterprise Type, 2020-2034
    • 11.5.1. Large Enterprise
    • 11.5.2. Small and Medium Enterprise
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Scale of Operation
    • 11.7.2. By Type of Synthesis Method Used
    • 11.7.3. By Enterprise Type
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 12.3.1. Preclinical/Clinical
    • 12.3.2. Commercial
  • 12.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 12.4.1. Non-chemical Synthesis Method
    • 12.4.2. Chemical Synthesis Method
  • 12.5. Market Value Forecast, by Enterprise Type, 2020-2034
    • 12.5.1. Large Enterprise
    • 12.5.2. Small and Medium Enterprise
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Scale of Operation
    • 12.7.2. By Type of Synthesis Method Used
    • 12.7.3. By Enterprise Type
    • 12.7.4. By Country/Sub-region

13. Latin America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 13.3.1. Preclinical/Clinical
    • 13.3.2. Commercial
  • 13.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 13.4.1. Non-chemical Synthesis Method
    • 13.4.2. Chemical Synthesis Method
  • 13.5. Market Value Forecast, by Enterprise Type, 2020-2034
    • 13.5.1. Large Enterprise
    • 13.5.2. Small and Medium Enterprise
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Scale of Operation
    • 13.7.2. By Type of Synthesis Method Used
    • 13.7.3. By Enterprise Type
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Scale of Operation, 2020-2034
    • 14.3.1. Preclinical/Clinical
    • 14.3.2. Commercial
  • 14.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
    • 14.4.1. Non-chemical Synthesis Method
    • 14.4.2. Chemical Synthesis Method
  • 14.5. Market Value Forecast, by Enterprise Type, 2020-2034
    • 14.5.1. Large Enterprise
    • 14.5.2. Small and Medium Enterprise
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Scale of Operation
    • 14.7.2. By Type of Synthesis Method Used
    • 14.7.3. By Enterprise Type
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Ambiopharm Inc
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Auspep
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bachem Holding AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. BCN Peptides
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Chinese Peptide Company
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. CordenPharma
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. CPC Scientific
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Creative Peptides
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. CSBio
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Hybio Pharmaceutical
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Peptide Institute, Inc.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. PolyPeptide Group
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. ScinoPharm
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. Senn Chemicals AG
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview

List of Tables

  • Table 01: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 02: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 03: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
  • Table 04: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 07: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 08: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
  • Table 09: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 11: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 12: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
  • Table 13: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 15: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 16: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
  • Table 17: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 19: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 20: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
  • Table 21: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
  • Table 23: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
  • Table 24: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034

List of Figures

  • Figure 01: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Scale of Operation, 2023
  • Figure 03: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Scale of Operation, 2023
  • Figure 04: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Type of Synthesis Method Used, 2023
  • Figure 05: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Type of Synthesis Method Used, 2023
  • Figure 06: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Enterprise Type, 2023
  • Figure 07: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Enterprise Type, 2023
  • Figure 08: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Region, 2023
  • Figure 09: Global Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 11: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 13: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 14: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 15: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
  • Figure 16: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 22: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 23: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 24: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 26: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
  • Figure 27: Europe Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 31: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 32: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 33: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 35: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
  • Figure 36: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 40: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 41: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 42: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 44: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
  • Figure 45: Latin America Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 49: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 50: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 51: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 53: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
  • Figure 54: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
  • Figure 58: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
  • Figure 59: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
  • Figure 60: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
  • Figure 62: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034